One of the additional assets is a gene therapy, known as RR001, which the company had been exploring for the treatment of solid tumors.
https://www.google.com/url?rct=j&sa=t&url=https://www.biopharma-reporter.com/Article/2022/05/31/evotec-expands-cell-therapy-manufacturing-with-acquisition&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw2tNHtv0MbwTYtBj4q69sYi
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.